Prothena Corp. PLC Registered Shares DL -,01

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

33.80%

Market Cap

1.15 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-4.02 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE7.304 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 12:33:36 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW7.3147.264
PREV. DAY'S PRICE7.426 (07/22)
CHANGE DAY BEFORE
-0.12
-1.64 %
52 WEEK HIGH / LOW9.85 (04/28)5.55 (07/23)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-2.56-2.10-4.020.11-1.07
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
---70.00-
PRICE - BOOK RATIO
3.481.531.83--
PRICE - SALES RATIO
21.175.5153.08--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A1KAVV
ISIN
IE00B91XRN20
SYMBOL
0PT
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
PROTHENA CORP. PLC DL-,01
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
53.72 Mil.
MARKET CAPITALISATION
1.15 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.01 %
-6.92 %
-18.40 %
-15.13 %
33.80 %
-87.20 %
-83.20 %
-8.88 %
HIGH7.738.859.859.859.8562.0071.009.85
LOW7.077.076.696.695.554.044.046.69

Dividende

pro Aktie
PROTHENA CORP. PLC DL-,01 does not deliver dividend information

Company profile

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.